Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 80.86 | (616.75) | (544.99)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | 125.99 | (671.14) | (498.26)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 361.18 | (435.12) | (341.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
| Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
| A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
| Currency | US Dollars |
| Share Price | $ 64.18 |
| Change Today | $ 0.89 |
| % Change | 1.41 % |
| 52 Week High | $68.15 |
| 52 Week Low | $29.84 |
| Volume | 1,147,704 |
| Shares Issued | 55.37m |
| Market Cap | $3,553.85m |
| RiskGrade | 332 |
| Strong Buy | 3 |
| Buy | 13 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 20 |

You are here: research